Progyny (PGNY)
NASDAQ:PGNY
US Market

Progyny (PGNY) Stock Price & Analysis

400 Followers

PGNY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$25.67 - $53.10
Previous Close$35.58
Volume782.50K
Average Volume (3M)854.56K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$140.99M
Total Debt (Recent Filing)$6.72M
Price to Earnings (P/E)84.6
Beta1.29
Next EarningsFeb 27, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)0.42
Shares Outstanding92,883,242
R-Squared0.26
Standard Deviation0.19
10 Day Avg. Volume602,838
30 Day Avg. Volume854,559
Price to Book (P/B)9.54
Price to Sales (P/S)5.71
Price to Cash Flow (P/CF)91.20
P/FCF Ratio121.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside37.16% Upside
Rating ConsensusStrong Buy
Alpha0.02
Number of Analyst Covering5


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PGNY FAQ

What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $25.67 and its highest was $53.10 in the past 12 months.
    What is Progyny’s market cap?
    Currently, no data Available
    When is Progyny’s upcoming earnings report date?
    Progyny’s upcoming earnings report date is Feb 27, 2023 which is in 22 days.
      How were Progyny’s earnings last quarter?
      Progyny released its earnings results on Nov 03, 2022. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.1.
        Is Progyny overvalued?
        According to Wall Street analysts Progyny’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Progyny pay dividends?
          Progyny does not currently pay dividends.
          What is Progyny’s EPS estimate?
          Progyny’s EPS estimate is $0.01.
            How many shares outstanding does Progyny have?
            Progyny has 92,883,240 shares outstanding.
              What happened to Progyny’s price movement after its last earnings report?
              Progyny reported an EPS of $0.13 in its last earnings report, beating expectations of $0.03. Following the earnings report the stock price went up 0.694%.
                Which hedge fund is a major shareholder of Progyny?
                Among the largest hedge funds holding Progyny’s share is Crestwood Capital Management, L.P.. It holds Progyny’s shares valued at 17M.

                  ---

                  Progyny Stock Smart Score

                  The Progyny stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Progyny

                  Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Elevance Health
                  Humana
                  Centene
                  Molina Healthcare
                  Healthequity

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis